Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances
Dept Health & Human Services (Apr), FDA Public Health Advisory, 2005
Bells Palsy with Ipsilateral Numbness
JNNP 76:1017-1018, Vanopdenbosch,L.J.,et al, 2005
[99mTc]TRODAT-1 SPECT Imaging Correlates with Odor Identification in Early Parkinson Disease
Neurol 64:1716-1720, Siderowf,A.,et al, 2005
Is This Patient Having a Stroke?
JAMA 293:2391-2402, Goldstein,L.B. &Simel,D.L., 2005
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
NEJM 352:2379-2388,2439, Petersen,R.C.,et al, 2005
Frontotemporal Lobar Degeneration
Arch Neurol 62:925-930, Johnson,J.K.,et al, 2005
Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005
Cognitive and Behavioral Effects of Lamotrigine and Topiramate in Healthy Volunteers
Neurol 64:2108-2114, Meador,K.J.,et al, 2005
Neurologic Manifestations in Welders with Pallidal MRI T1 Hyperintensity
Neurol 64:2033-2039,2001, Josephs,K.A.,et al, 2005
Long-term Donepezil Treatment in 565 Patients with Alzheimer's Disease (AD2000): Randomised Double-Blind Trial
Lancet 363:2105-2115,2100, AD2000 Collaborative Group, 2004
Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women
JAMA 291:2947-2958,3005, Shumaker,S.A.,et al, 2004
Most Cases of Dementia with Hippocampal Sclerosis May Represent Frontotemporal Dementia
Neurol 63:538-542, Hatanpaa,K.J.,et al, 2004
Idiopathic Hyposmia As a Preclinical Sign of Parkinson's Disease
Ann Neurol 56:173-181,169, Ponsen,M.M.,et al, 2004
The Neurological Complications of Bariatric Surgery
Arch Neurol 61:1185-1189, Berger,J.R., 2004
Economic Evaluation of Donepezil in Moderate to Severe Alzheimer Disease
Neurol 63:644-650, Feldman,H.,et al, 2004
Efficacy of Donepezil in Mild Cognitive Impairment
Neurol 63:651-657, Salloway,S.,et al, 2004
HSV-2 Sacral Radiculitis (Elsberg Syndrome)
Neurol 63:758-759, Eberhardt,O.,et al, 2004
Driver Route-Following and Safety Errors in Early Alzheimer Disease
Neurol 63:832-837, Uc,E.Y.,et al, 2004
Monoamine Oxide Type B Inhibitors in Early Parkinson's Disease:Meta-Analysis of 17 Randomised Trials Involving 3525 Patients
BMJ 329:593-596, Ives,N.J.,et al, 2004
A Multimodal Assessment of Driving Performance in HIV Infection
Neurol 63:1417-1422, Marcotte,T.D.,et al, 2004
Progressive Posterior Cortical Dysfunction
Neurol 63:1175-1180, Renner,J.A.,et al, 2004
Clinical, Genetic, and Neuropathologic Characteristics of Posterior Cortical Atrophy
Neurol 63:1168-1174, Tang-Wai,D.F.,et al, 2004
Hyperinsulinemia and Risk of Alzheimer Disease
Neurol 63:1187-1192, Luchsinger,J.A.,et al, 2004
Spinal Cord Infarction: Clinical and Magnetic Resnoance Imaging Findings and Short Term Outcome
JNNP 75:1431-1435, Masson,C.,et al, 2004
Autonomic Failure as the Initial Presentation of Parkinson Disease and Dementia with Lewy Bodies
Neurol 63:1093-1095, Kaufmann,H.,et al, 2004
Memory Complaints in Nondemented Men Predict Future Pathologic Diagnosis of Alzheimer Disease
Neurol 63:1960-1961, Jorm,A.F.,et al, 2004
Mixed Dementia, Emerging Concepts and Therapeutic Implications
JAMA 292:2901-2908, Langa,K.M.,et al, 2004
Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements
Arch Neurol 61:82-88, Zandi,P.P.,et al, 2004
The Redefinition of TIA, The Uses and Limitations of DWI in Acute Ischemic Cerebrovascular Syndromes
Neurol 62:359-360, Warach,S.&Kidwell,C.S., 2004
DWI Abnormalities and Clinical Characteristics in TIA Patients
Neurol 62:376-380,359, Inatomi,Y.,et al, 2004
Migraine
Lancet 363:381-391, Silberstein,S.D., 2004
Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil, A Randomized Controlled Trial
JAMA 291:317-324, Tariot,P.N.,et al, 2004
Brain Metastases
The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004
Imaging Cerebral Atrophy:Normal Ageing to Alzheimer's Disease
Lancet 363:392-394, Fox,N.C.&Schott,J.M., 2004
Ophthalmologic Features of Parkinson's Disease
Neurol 62:177-180, Biousse,V.,et al, 2004
Comparison of Different MRI Brain Atrophy Rate Measures with Clinical Disease Progression in AD
Neurol 62:591-600, Jack, Jr.,C.R.,et al, 2004
Factors Influencing the Decision to Perform Carotid Endarterectomy
Neurol 62:803-805, Hill,M.,D.,et al, 2004
Acute Aphasia in Multiple Sclerosis, A Multicenter Study of 22 Patients
Neurol 62:974-977, Lacour,A.,et al, 2004
Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function
Arch Neurol 61:661-666, Arvanitakis,Z.,et al, 2004
An Unusual Cause of Psychosis
Lancet 363:1522, Singh,S.,et al, 2004
Fibromuscular Dysplasia
NEJM 350:1862-1871, Slovut,D.P. &Olin,J.W., 2004
Size of the Treatment Effect on Cognition of Cholinesterase Inhibition in Alzheimer's Disease
JNNP 75:677-685, Rockwood,K., 2004
Estimating Prognosis for Nursing Home Residents with Advanced Dementia
JAMA 291:2734-2740, Mitchell,S.L.,et al, 2004
Recurrent Acroparaesthesia During Febrile Infections
Lancet 363:1698, Bodamer,O.A.,et al, 2004
Clinicopath Conf., Leprosy
NEJM 350:166-176, Case 1-2004, 2004
Multiple Actinomycosis Brain Abscesses
Presse Med 33:318-320, Liotier,J.,et al, 2004
Potassium Channel Antibody-Associated Encephalopathy: A Potentially Immunotherapy-Responsive Form of Limbic Encepahlitis
Brain 127:701-712, Vincent,A.,et al, 2004
Unilateral Brachial Plexopathy Associated with West Nile Virus Meningoencephalitis
CID 36:162-1630, Almhanna,K.,et al, 2003
The Topography of Metabolic Deficits in Posterior Cortical Atrophy (the Visual Variant of Alzheimers Disease) with FDG-PET
JNNP 74:1521-1529, Nestor,P.J.,et al, 2003
Heralding Manifestations of Basilar Artery Occlusion with Lethal or Severe Stroke
JNNP 74:1621-1626, von Campe,G.,et al, 2003